Skip to search.
 FTSE 100 Down 0.11%
Streaming
Ticker Tape: On

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
305.03 Down 6.65(2.13%) 18:54 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:311.68
Open:312.36
Bid:304.74 x 300
Ask:305.43 x 100
1y Target Est:344.25
Beta:0.81
Next Earnings Date: 8-May-14REGN Earnings announcement
Day's Range:302.53 - 312.88
52wk Range:206.30 - 352.49
Volume:319,378
Avg Vol (3m):1,190,530
Market Cap:30.24b
P/E (ttm):80.06
EPS (ttm):3.81
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNDown 2.13%30.24b
AMGNDown 5.69%84.95b
NVSDown 0.38%209.20b
RHHBYUp 0.03%123.21b

Key Statistics

Forward P/E (1 yr):45.20
P/S (ttm):14.68
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :4.36
Quarterly EPS Est (Mar-14) :0.95
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):2.35

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback